Aldebaran Capital, LLC
In its 13F for Q4 2025 (holdings as of December 31, 2025, filed February 12, 2026), Aldebaran Capital, LLC reported 35 stock positions worth $111.5 million. Its top holding was Berkshire Hathaway Class B (BRK.B) at 18.1% of the portfolio, followed by Eli Lilly (LLY, 8.7%) and Microsoft (MSFT, 7.9%). Compared with Q3 2025, it opened 3 new positions, sold out of 1, added to 3 and reduced 25. The biggest buy was Eli Lilly (LLY, shares +16%) and the biggest sale Occidental Petroleum (OXY, shares −5%).
- Most Recent 13F
- Q2 2026
- Location
- CARMEL, IN
- CIK
- 0001448430
- Portfolio Value
- $111.5M (Q4 2025)
- SEC Filing
- 0001376474-26-000164 ↗ filed Feb 12, 2026
Holdings Value
Holdings 35 stocks · $111.5M
| BRK.B Berkshire Hathaway Inc. Class B | 18.11% | 40,187 | $20.2M | Reduce -4.1% |
| LLY Eli Lilly & Co. | 8.70% | 9,032 | $9.7M | Add +16.1% |
| MSFT Microsoft Corp. | 7.87% | 18,140 | $8.8M | Reduce -4.5% |
| BG Bunge Global SA | 7.51% | 93,995 | $8.4M | Reduce -3.4% |
| OXY Occidental Petroleum Corp. | 5.89% | 159,634 | $6.6M | Reduce -5.2% |
| BAC Bank of America Corp. filed as BANK AMERICA CORP | 5.19% | 105,312 | $5.8M | Reduce -3.1% |
| IWS iShares Russell Mid-Cap Valu | 5.08% | 40,177 | $5.7M | Add +2.2% |
| SU Suncor Energy Inc. | 4.59% | 115,311 | $5.1M | Reduce -3.7% |
| CVX Chevron Corp. | 3.62% | 26,521 | $4.0M | Reduce -3.8% |
| JPM JPMorgan Chase & Co. | 3.26% | 11,282 | $3.6M | Reduce -1.7% |
| CATO Cato Corp. Class A | 2.89% | 1,042,448 | $3.2M | Add +1.1% |
| ACRS Aclaris Therapeutics Inc. | 2.58% | 954,262 | $2.9M | Reduce -3.4% |
| BCI Abrdn Bloomberg All Commodit filed as ABRDN ETFS | 2.52% | 144,053 | $2.8M | Reduce -3.4% |
| FCX Freeport-McMoran Inc. | 2.22% | 48,835 | $2.5M | Reduce -5.6% |
| VZ Verizon Communications Inc. | 2.19% | 59,948 | $2.4M | Reduce -5.4% |
| AMLX Amylyx Pharmaceuticals Inc. | 2.15% | 198,508 | $2.4M | Reduce -2.9% |
| CENX Century Aluminum Company | 2.03% | 57,700 | $2.3M | Reduce -3.1% |
| MOH Molina Healthcare Inc. | 1.97% | 12,651 | $2.2M | New |
| SIRI Sirius XM Holdings Inc. | 1.91% | 106,347 | $2.1M | Reduce -5.1% |
| ENB Enbridge Inc. | 1.72% | 40,109 | $1.9M | Reduce -3.1% |
| BRK.A Berkshire Hathaway Inc. Class A | 1.35% | 2 | $1.5M | No change |
| PATK Patrick Industries Inc. | 1.35% | 13,872 | $1.5M | Reduce -2.1% |
| RELL Richardson Elec Ltd. | 1.16% | 118,979 | $1.3M | Reduce -17.2% |
| TECX Tectonic Therapeutic Inc. | 0.70% | 37,353 | $779K | Reduce -3.0% |
| PMVP PMV Pharmaceuticals Inc. | 0.54% | 477,988 | $597K | Reduce -5.2% |
| KZR Kezar Life Sciences Inc. | 0.45% | 80,630 | $507K | New |
| AN2 THEREAPEUTICS INC | 0.39% | 376,770 | $430K | Reduce -4.1% |
| Duke Energy Corp New | 0.38% | 3,600 | $422K | No change |
| GE General Electric Company filed as GE Aerospace | 0.35% | 1,251 | $385K | Reduce -0.4% |
| F Ford Motor Co. filed as FORD MTR CO | 0.32% | 27,500 | $361K | Reduce -2.3% |
| MBIN Merchants Bancorp | 0.31% | 10,125 | $345K | No change |
| AVIR Atea Pharmaceuticals Inc. | 0.29% | 90,529 | $323K | New |
| GEV GE Vernova Inc. | 0.19% | 332 | $217K | No change |
| IMA Imagenebio Inc. | 0.12% | 19,070 | $132K | Reduce -2.5% |
| OKUR Onkure Therapeutics Inc. Class A | 0.11% | 41,284 | $120K | Reduce -6.2% |
Portfolio Sells Q3 2025 → Q4 2025
| OXY Occidental Petroleum Corp. | Reduce -5.2% | 5.89% | −1.42 |
| BRK.B Berkshire Hathaway Inc. Class B | Reduce -4.1% | 18.11% | −1.24 |
| MSFT Microsoft Corp. | Reduce -4.5% | 7.87% | −1.17 |
| TECK Teck Resources Ltd.-CLS B | Sold out | 0.00% | −0.49 |
| SIRI Sirius XM Holdings Inc. | Reduce -5.1% | 1.91% | −0.49 |
| BCI Abrdn Bloomberg All Commodit | Reduce -3.4% | 2.52% | −0.43 |
| AMLX Amylyx Pharmaceuticals Inc. | Reduce -2.9% | 2.15% | −0.40 |
| VZ Verizon Communications Inc. | Reduce -5.4% | 2.19% | −0.37 |
| CVX Chevron Corp. | Reduce -3.8% | 3.62% | −0.31 |
| ENB Enbridge Inc. | Reduce -3.1% | 1.72% | −0.20 |
| RELL Richardson Elec Ltd. | Reduce -17.2% | 1.16% | −0.13 |
| PMVP PMV Pharmaceuticals Inc. | Reduce -5.2% | 0.54% | −0.11 |
| AN2 THEREAPEUTICS INC | Reduce -4.1% | 0.39% | −0.07 |
| JPM JPMorgan Chase & Co. | Reduce -1.7% | 3.26% | −0.07 |
| IMA Imagenebio Inc. | Reduce -2.5% | 0.12% | −0.03 |
| SU Suncor Energy Inc. | Reduce -3.7% | 4.59% | −0.01 |
| OKUR Onkure Therapeutics Inc. Class A | Reduce -6.2% | 0.11% | −0.00 |
| GE General Electric Company | Reduce -0.4% | 0.35% | −0.00 |
| PATK Patrick Industries Inc. | Reduce -2.1% | 1.35% | +0.00 |
| F Ford Motor Co. | Reduce -2.3% | 0.32% | +0.01 |
| BAC Bank of America Corp. | Reduce -3.1% | 5.19% | +0.05 |
| TECX Tectonic Therapeutic Inc. | Reduce -3.0% | 0.70% | +0.14 |
| BG Bunge Global SA | Reduce -3.4% | 7.51% | +0.25 |
| FCX Freeport-McMoran Inc. | Reduce -5.6% | 2.22% | +0.36 |
| CENX Century Aluminum Company | Reduce -3.1% | 2.03% | +0.42 |
| ACRS Aclaris Therapeutics Inc. | Reduce -3.4% | 2.58% | +0.85 |
Portfolio Buys Q3 2025 → Q4 2025
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 39 | $133.1M | BRK.B, LLY, MSFT, BG, IWS |
| Q1 2026 | 42 | $130.5M | BRK.B, OXY, BG, LLY, MSFT |
| Q4 2025 | 35 | $111.5M | BRK.B, LLY, MSFT, BG, OXY |
| Q3 2025 | 33 | $108.9M | BRK.B, MSFT, OXY, BG, LLY |
| Q2 2025 | 34 | $101.3M | BRK.B, MSFT, BG, OXY, LLY |
| Q1 2025 | 40 | $105.5M | BRK.B, OXY, BG, MSFT, LLY |
| Q4 2024 | 36 | $105.0M | BRK.B, MSFT, OXY, BG, BAC |
| Q3 2024 | 36 | $109.3M | BRK.B, MSFT, BG, OXY, LLY |
| Q2 2024 | 35 | $107.1M | BRK.B, OXY, BG, MSFT, LLY |
| Q1 2024 | 32 | $104.7M | BRK.B, OXY, BG, MSFT, LLY |